July-August 2004

Under way at 20 US centers, the trial compares surgery with optimal pharmacotherapy for patients with mesial temporal lobe epilepsy.

UAB will receive $3.5 million from NHLBI over the next 5 years as a part of the Regional Coordinating Centers for Resuscitation in North America.

The ADRC provides comprehensive treatment for Alzheimer’s disease (AD) and is a leading center for research aimed at preventing and managing the disease.

UAB directs national sudy of drug that may repair sun-damaged skin and prevent skin cancer development.

UAB directs national sudy of drug that may repair sun-damaged skin and prevent skin cancer development.

$2.85 million, 5-year grant establishes one of six centers at UAB, joining Harvard, Yale, Vanderbilt, Case Western Reserve, and Texas-Southwestern.

University Hospital's 885,000 sq ft North Pavilion prepared for occupancy.

Grant focuses on more functional, long-lasting TMJ implants.

CI Movement Therapy named one of 10 most important translational neuroscience accomplishments.

Grant will establish the Evelyn F. McKnight Brain Institute at UAB.

Cholesterol-loweing statins may help prevent dementia-related memory loss.

National Heart, Lung, and Blood Institute, American College of Cardiology, and American Heart Association endorse new guidelines.

Richard Shane Tubbs, PhD, named director of the Anatomical Donor Program and Gross Anatomy Laboratory.

UAB scientist who helped define the human immune system in the mid-1960s has discovered a new type of immune system in the sea lamprey.

UAB infectious disease experts will evaluate new treatments.

The 10 centers will attack the dismal outlook for people who require resuscitation when they severely injured or suffer a cardiac heart attack outside a hospital.

Gastrointestinal hormone PYY3-36 does not decrease appetite and weight gain in rodents, as previously thought.